Anti-recoverin antibodies in a cerebellar syndrome without retinal involvement
Keywords:
recoverin, cerebellitis, anti-recoverin antibodies, dizziness, ataxia, dysarthriaAbstract
Anti-recoverin antibodies are typically found in cancer-associated retinopathy or autoimmune diseases. We present a case of anti-recoverin positive cerebellar syndrome without any signs of malignancy or retinopathy. The patient was treated with steroids and intravenous immunoglobulins, resulting in improvements in both cognitive and motor symptoms.
References
Ohguro H, Nakazawa M. Pathological roles of recoverin in cancer-associated retinopathy. Adv Exp Med Biol 2002;514:109-24. doi: 10.1007/978-1-4615-0121-3_7.
Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9- and caspase 3-dependent pathway. J Neuroimmunol 2002 Nov;132(1-2):72-82. doi: 10.1016/s0165-5728(02)00314-4.
Braithwaite T, Vugler A, Tufail A. Autoimmune retinopathy. Ophthalmologica 2012;228(3):131-42. doi: 10.1159/000338240.
Li M, Cheng G, Wang Z et al. Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus. Lupus 2020 Oct;29(11):1346-1352. doi: 10.1177/0961203320940780.
Ávila GM, Escamilla EE, González AP, Corral JAM, Fernández CP, Marcos AR. Antineuronal antibodies: Anti-recoverin in neurological syndromes without retinopathy. SARS-CoV2 infection as a trigger. Neurologia (Engl Ed) 2022 Jun;37(5):409-410. doi: 10.1016/j.nrleng.2021.07.003.
Paterlini M, Revilla V, Grant AL, Wisden W. Expression of the neuronal calcium sensor protein family in the rat brain. Neuroscience 2000;99(2):205-16. doi: 10.1016/s0306-4522(00)00201-3.
Ramos-Ruperto L, Busca-Arenzana C, Boto-de Los Bueis A, Schlincker A, Arnalich-Fernández F, Robles-Marhuenda Á. Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach? Ocul Immunol Inflamm 2021 Feb 17;29(2):399-402. doi: 10.1080/09273948.2019.1681471.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Matteo Minetti, Giulia Balella, Lucia Zinno
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
